H-ISDN meta-analysisHot Line 6Heart Failure
Hydralazine-Isosorbide Dinitrate in Heart Failure With Reduced Ejection Fraction
Hydralazine-isosorbide dinitrate in heart failure with reduced ejection fraction: a meta-analysis
Presenting authorMorten SchouHeart Failure / Cardiomyopathy · University of CopenhagenMorten Schou is a Clinical Professor in the Department of Clinical Medicine at the University of Copenhagen and a cardiologist in the Department of Cardiology at Herlev-Gentofte Hospital. He is a specialist in internal medicine and cardiology with a subspecialty in heart failure, cardiomyopathies, and echocardiography. His research focuses on cardio-renal interactions, the interplay between type 2 diabetes and heart failure, and he has participated in multiple national and international randomized clinical trials.
Overview
Pending H-ISDN meta-analysis in HFrEF leaves optimal vasodilator use unresolved; awaits synthesis before practice or trial updates.
Key result
Hydralazine-isosorbide dinitrate outcomes in patients with heart failure with reduced ejection fraction are currently pending presentation from a late-breaking meta-analysis.
Discussion
Expert reaction lands here the moment H-ISDN meta-analysis reports.
Key Points
- Evaluation of hydralazine-isosorbide dinitrate aims to assess mortality benefits in heart failure with reduced ejection fraction, targeting optimal vasodilator regimens.
- Planned primary and secondary cardiovascular outcomes will synthesize effect sizes across trials, though quantitative efficacy metrics remain pending formal presentation.
- Meta-analysis methodology aggregates existing randomized trial evidence to clarify guideline indications for hydralazine-isosorbide dinitrate in current clinical practice.
Structured PICO
Does hydralazine-isosorbide dinitrate improve outcomes in heart failure with reduced ejection fraction?
P
Population
Heart failure with reduced ejection fraction
I
Intervention
Hydralazine-isosorbide dinitrate
Results are pending for this meta-analysis of hydralazine-isosorbide dinitrate in HFrEF.
Main Result
Absolute Event Rate: 0% vs 0%